Selected research
Industry Research
Meperidine (Demerol) Industry Research Report 2026
Market perspective
The global Meperidine (Demerol) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Meperidine (Demerol) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Meperidine (Demerol) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Meperidine (Demerol) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Meperidine (Demerol) include Actavis Plc, Boehringer Ingelheim, Egalet, Endo Pharmaceuticals Inc, Janssen Pharmaceuticals, Mallinckrodt Pharmaceuticals, Purdue Pharma, Sun Pharmaceutical Industries Ltd and Pfizer Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Meperidine (Demerol) market in terms of revenue (US$ million) and, where applicable, sales volume (mg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/mg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Meperidine (Demerol) Market by Company
Actavis Plc
Boehringer Ingelheim
Egalet
Endo Pharmaceuticals Inc
Janssen Pharmaceuticals
Mallinckrodt Pharmaceuticals
Purdue Pharma
Sun Pharmaceutical Industries Ltd
Pfizer Inc
Sanofi
Meperidine (Demerol) Segment by Type
Powder
Liquid
Meperidine (Demerol) Segment by Application
Anesthesia
Cough Suppressant
Diarrhea suppressant
Meperidine (Demerol) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meperidine (Demerol) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Meperidine (Demerol) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meperidine (Demerol).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Meperidine (Demerol) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Meperidine (Demerol) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Meperidine (Demerol) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Powder
- Liquid
Applications
- Anesthesia
- Cough Suppressant
- Diarrhea suppressant
Companies covered
- Actavis Plc
- Boehringer Ingelheim
- Egalet
- Endo Pharmaceuticals Inc
- Janssen Pharmaceuticals
- Mallinckrodt Pharmaceuticals
- Purdue Pharma
- Sun Pharmaceutical Industries Ltd
- Pfizer Inc
- Sanofi
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Meperidine (Demerol) Market Size (2021-2032)
- 2.2.2 Global Meperidine (Demerol) Sales (2021-2032)
- 2.2.3 Global Meperidine (Demerol) Market Average Price (2021-2032)
- 2.3 Meperidine (Demerol) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Powder
- 2.3.3 Liquid
- 2.4 Meperidine (Demerol) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Anesthesia
- 2.4.3 Cough Suppressant
- 2.4.4 Diarrhea suppressant
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Meperidine (Demerol) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Meperidine (Demerol) Sales (mg) of Manufacturers (2021-2026)
- 3.3 Global Meperidine (Demerol) Revenue of Manufacturers (2021-2026)
- 3.4 Global Meperidine (Demerol) Average Price by Manufacturers (2021-2026)
- 3.5 Global Meperidine (Demerol) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Meperidine (Demerol), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Meperidine (Demerol), Product Type & Application
- 3.8 Global Manufacturers of Meperidine (Demerol), Established Date
- 3.9 Global Meperidine (Demerol) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Actavis Plc
- 4.1.1 Actavis Plc Company Information
- 4.1.2 Actavis Plc Business Overview
- 4.1.3 Actavis Plc Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Actavis Plc Meperidine (Demerol) Product Portfolio
- 4.1.5 Actavis Plc Recent Developments
- 4.2 Boehringer Ingelheim
- 4.2.1 Boehringer Ingelheim Company Information
- 4.2.2 Boehringer Ingelheim Business Overview
- 4.2.3 Boehringer Ingelheim Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Boehringer Ingelheim Meperidine (Demerol) Product Portfolio
- 4.2.5 Boehringer Ingelheim Recent Developments
- 4.3 Egalet
- 4.3.1 Egalet Company Information
- 4.3.2 Egalet Business Overview
- 4.3.3 Egalet Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Egalet Meperidine (Demerol) Product Portfolio
- 4.3.5 Egalet Recent Developments
- 4.4 Endo Pharmaceuticals Inc
- 4.4.1 Endo Pharmaceuticals Inc Company Information
- 4.4.2 Endo Pharmaceuticals Inc Business Overview
- 4.4.3 Endo Pharmaceuticals Inc Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Endo Pharmaceuticals Inc Meperidine (Demerol) Product Portfolio
- 4.4.5 Endo Pharmaceuticals Inc Recent Developments
- 4.5 Janssen Pharmaceuticals
- 4.5.1 Janssen Pharmaceuticals Company Information
- 4.5.2 Janssen Pharmaceuticals Business Overview
- 4.5.3 Janssen Pharmaceuticals Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Janssen Pharmaceuticals Meperidine (Demerol) Product Portfolio
- 4.5.5 Janssen Pharmaceuticals Recent Developments
- 4.6 Mallinckrodt Pharmaceuticals
- 4.6.1 Mallinckrodt Pharmaceuticals Company Information
- 4.6.2 Mallinckrodt Pharmaceuticals Business Overview
- 4.6.3 Mallinckrodt Pharmaceuticals Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Mallinckrodt Pharmaceuticals Meperidine (Demerol) Product Portfolio
- 4.6.5 Mallinckrodt Pharmaceuticals Recent Developments
- 4.7 Purdue Pharma
- 4.7.1 Purdue Pharma Company Information
- 4.7.2 Purdue Pharma Business Overview
- 4.7.3 Purdue Pharma Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Purdue Pharma Meperidine (Demerol) Product Portfolio
- 4.7.5 Purdue Pharma Recent Developments
- 4.8 Sun Pharmaceutical Industries Ltd
- 4.8.1 Sun Pharmaceutical Industries Ltd Company Information
- 4.8.2 Sun Pharmaceutical Industries Ltd Business Overview
- 4.8.3 Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Sun Pharmaceutical Industries Ltd Meperidine (Demerol) Product Portfolio
- 4.8.5 Sun Pharmaceutical Industries Ltd Recent Developments
- 4.9 Pfizer Inc
- 4.9.1 Pfizer Inc Company Information
- 4.9.2 Pfizer Inc Business Overview
- 4.9.3 Pfizer Inc Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pfizer Inc Meperidine (Demerol) Product Portfolio
- 4.9.5 Pfizer Inc Recent Developments
- 4.10 Sanofi
- 4.10.1 Sanofi Company Information
- 4.10.2 Sanofi Business Overview
- 4.10.3 Sanofi Meperidine (Demerol) Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sanofi Meperidine (Demerol) Product Portfolio
- 4.10.5 Sanofi Recent Developments
5 Global Meperidine (Demerol) Market Scenario by Region
- 5.1 Global Meperidine (Demerol) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Meperidine (Demerol) Sales by Region: 2021-2032
- 5.2.1 Global Meperidine (Demerol) Sales by Region: 2021-2026
- 5.2.2 Global Meperidine (Demerol) Sales by Region: 2027-2032
- 5.3 Global Meperidine (Demerol) Revenue by Region: 2021-2032
- 5.3.1 Global Meperidine (Demerol) Revenue by Region: 2021-2026
- 5.3.2 Global Meperidine (Demerol) Revenue by Region: 2027-2032
- 5.4 North America Meperidine (Demerol) Market Facts & Figures by Country
- 5.4.1 North America Meperidine (Demerol) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Meperidine (Demerol) Sales by Country (2021-2032)
- 5.4.3 North America Meperidine (Demerol) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Meperidine (Demerol) Market Facts & Figures by Country
- 5.5.1 Europe Meperidine (Demerol) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Meperidine (Demerol) Sales by Country (2021-2032)
- 5.5.3 Europe Meperidine (Demerol) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Meperidine (Demerol) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Meperidine (Demerol) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Meperidine (Demerol) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Meperidine (Demerol) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Meperidine (Demerol) Market Facts & Figures by Country
- 5.7.1 South America Meperidine (Demerol) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Meperidine (Demerol) Sales by Country (2021-2032)
- 5.7.3 South America Meperidine (Demerol) Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Meperidine (Demerol) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Meperidine (Demerol) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Meperidine (Demerol) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Meperidine (Demerol) Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Meperidine (Demerol) Sales by Type (2021-2032)
- 6.1.1 Global Meperidine (Demerol) Sales by Type (2021-2032) & (mg)
- 6.1.2 Global Meperidine (Demerol) Sales Market Share by Type (2021-2032)
- 6.2 Global Meperidine (Demerol) Revenue by Type (2021-2032)
- 6.2.1 Global Meperidine (Demerol) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Meperidine (Demerol) Revenue Market Share by Type (2021-2032)
- 6.3 Global Meperidine (Demerol) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Meperidine (Demerol) Sales by Application (2021-2032)
- 7.1.1 Global Meperidine (Demerol) Sales by Application (2021-2032) & (mg)
- 7.1.2 Global Meperidine (Demerol) Sales Market Share by Application (2021-2032)
- 7.2 Global Meperidine (Demerol) Revenue by Application (2021-2032)
- 7.2.1 Global Meperidine (Demerol) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Meperidine (Demerol) Revenue Market Share by Application (2021-2032)
- 7.3 Global Meperidine (Demerol) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Meperidine (Demerol) Value Chain Analysis
- 8.1.1 Meperidine (Demerol) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Meperidine (Demerol) Production Mode & Process
- 8.2 Meperidine (Demerol) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Meperidine (Demerol) Distributors
- 8.2.3 Meperidine (Demerol) Customers
9 Global Meperidine (Demerol) Analyzing Market Dynamics
- 9.1 Meperidine (Demerol) Industry Trends
- 9.2 Meperidine (Demerol) Industry Drivers
- 9.3 Meperidine (Demerol) Industry Opportunities and Challenges
- 9.4 Meperidine (Demerol) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst